Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

NCT06525766 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage IV Breast Cancer AJCC v8
Estrogen-receptor-positive Breast Cancer
Metastatic HER2-Negative Breast Carcinoma
Metastatic Breast Cancer

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
DRUG: Capecitabine
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
OTHER: Questionnaire Administration

Sponsor

Mayo Clinic